Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Race and precision medicine: is it time for an upgrade?

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Jorde LB, Wooding SP. Genetic variation, classification and ‘race’. Nat Genet. 2004;36(11 Suppl):S28–33.

    CAS  Article  Google Scholar 

  2. MacEachern S. The concept of race in contemporary anthropology. Race and Ethnicity: The United States and the World 2011, 34–57

  3. Officers A. Coordinators for the ACRGTA, lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–97.

    Article  Google Scholar 

  4. Brody H, Hunt LM. BiDil: assessing a race-based pharmaceutical. Ann Fam Med. 2006;4:556–60.

    Article  Google Scholar 

  5. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA . 2014;311:507–20.

    CAS  Article  Google Scholar 

  6. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934.

    Article  Google Scholar 

  7. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431–46.

    CAS  Article  Google Scholar 

  8. Jones NA, Bullock J (2012). The two or more races population. pp 1–23 United States: U.S. Census Bureau; 2010.

  9. United State Census Bureau. Midwest Home to Most of the Counties With Decreases in Median Age. 2018 https://www.census.gov/newsroom/press-releases/2018/popest-characteristics.html. June 22nd 2018.

  10. Roman YM, Culhane-Pera KA, Menk J, Straka RJ. Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong. Per Med. 2016;13:429–40.

    CAS  Article  Google Scholar 

  11. Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.

    Article  Google Scholar 

  12. A global reference for human genetic variation, Nature volume 2015;526:68–74.

  13. Ahmed S, Zhou Z, Zhou J, Chen SQ. Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine. Genom, Proteom Bioinforma. 2016;14:298–313.

    Article  Google Scholar 

  14. Wu AH, White MJ, Oh S, Burchard E. The Hawaii clopidogrel lawsuit: the possible effect on clinical laboratory testing. Pers Med. 2015;12:179–81.

    CAS  Article  Google Scholar 

  15. Adams SA, Petersen C. Precision medicine: opportunities, possibilities, and challenges for patients and providers. J Am Med Inform Assoc. 2016;23:787–90.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Youssef M. Roman Pharm.D., Ph.D..

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Roman, Y.M. Race and precision medicine: is it time for an upgrade?. Pharmacogenomics J 19, 1–4 (2019). https://doi.org/10.1038/s41397-018-0046-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41397-018-0046-0

Further reading

Search

Quick links